ASTHMA, ECZEMA, PSORIASIS AND CHRONIC HIVES

We are currently enrolling 3 asthma studies. The 'entry criteria" vary a bit from study to study. Here are criteria for 2 of the studies: Orion Clinical Research is enrolling adults with persistent asthma in a clinical research study. You may be able to participate if you:   • Are 18 to 75 years of age • Have a medical history of asthma • Are on a daily asthma treatment regimen • Had 1 asthma exacerbation in the past 12 months requiring corticosteroid. Qualified participants will receive investigational drug and study-related care. If you qualify, you may be provided reimbursement. Additional criteria may apply. Orion Clinical Research is enrolling adolescent and adults with persistent asthma in a clinical research study. You may be able to participate if you:   • Are 12 to 80 years of age • Have a medical history of asthma in the past 1 year • Are on an asthma treatment regimen for at least 4 weeks • Had 1 asthma exacerbation in the past 12 months requiring corticosteroid Qualified participants will receive investigational drug and study-related care. If you qualify, you may be provided reimbursement. Additional criteria may apply. ECZEMA Orion Clinical Research is enrolling participants with Atopic Dermatitis (eczema) in a clinical research study. You may qualify if you: ✓ Are 18 years or age or older ✓ Have a medical history of chronic eczema for at least 12 months ✓ Experience an inadequate response to your topical corticosteroid cream (TCS) in the last 6 months Additional criteria may apply. There is no cost to participate. All study-related care and medication are provided at no cost. You may be eligible to be compensated for your time and travel. CALL 512-492-3797 FOR MORE INFORMATION NEW FLU VACCINE STUDY Could you be part of the next vaccine breakthrough? mRNA vaccines have changed the way we fight infectious diseases. Introducing Pfizer’s phase 3 research study for an investigational flu vaccine using mRNA technology. Research is ongoing to evaluate an investigational mRNA flu vaccine. By participating in this study, you can help us learn if this investigational vaccine is safe and can help the body produce antibodies which may help fight off the flu. When you participate in a study, you’re helping to represent both your community and all people who are affected by the flu and other infectious diseases. Your participation could make a difference. This research study is enrolling people who: Are at least 18 years of age Are generally healthy or have stable chronic conditions Have not received an investigational or licensed flu vaccine in the last six months There will be other study requirements the study team will discuss with you if you participate in this study. Participation lasts for about six months Ready to learn more? Contact the study team: [Or visit [www.fluvaccinestudy.com/mrnaphase3] for more information.]